A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Clinical trial NCT06157892 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06157892
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Gastroesophageal Junction Adenocarcinoma HER2 Low Breast Neoplasms HER2 Positive Breast Neoplasms Stomach Neoplasms Triple Negative Breast Neoplasms Metastatic Breast Cancer Metastatic Gastric Cancer Advanced Breast Cancer Advanced Gastric Cancer

Start date: 2024-05-20
Primary completion: 2029-07-28
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.